LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Stoelzle – 15th May 2025

Quality by Design in the Development: Benefit or Bureaucratic Burden?

Petra Botzem and Dr Thomas Hille of LTS Lohmann
answer this provoking question in their paper on the
ICH guideline Q8, with focus on Transdermal Delivery
Systems (TDS) development, providing insight on why
it is beneficial. Due to its well-structured content, the
referenced guideline ICH Q8 describes well-established
development strategies, supplying a platform for
controlled and organised development, not only for
TDS.

Scott Pharma – 25.03.2025
Bespak – 21.05.2025
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
L.B. Bohle – 08.04.2025
Drug Discovery 2025, ELRIG – 04.07.2025